Alpine Global Management, LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 92 filers reported holding CTI BIOPHARMA CORP in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Alpine Global Management, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2022$118,000
+12.4%
25,326
-22.6%
0.02%
-28.6%
Q4 2020$105,000–32,720–0.02%–
 Download
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Legal & General Group Plc 9,340$84,9010.00%
UBS ASSET MANAGEMENT AMERICAS INC 92,700$389,3400.00%
FNY Investment Advisers, LLC 20$00.00%
View complete list of CTI BIOPHARMA CORP shareholders